TFF1 Mouse Monoclonal Antibody [Clone ID: SPM573]

CAT#: AM50172PU-T

TFF1 mouse monoclonal antibody, clone SPM573, Purified

Size: 20 ug 100 ug


USD 315.00

2 Weeks*

Size
    • 20 ug

Product Images

Other products for "TFF1"

Specifications

Product Data
Clone Name SPM573
Applications FC, IF, IHC, IP, WB
Recommended Dilution Flow Cytometry: 0.5-1 µg/million cells. 
Immunofluorescence: 0.5-1 µg/ml.
Western Blotting: 0.5-1 µg/ml. 
Immunoprecipitation: 0.5-1 µg/500 µg protein lysate. 
Immunohistochemistry on Formalin-Fixed Paraffin Sections: 0.5-1 µg/ml for 30 minutes at RT. 
Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
Positive Control: Spent medium of MCF-7 cells, treated with estrogen. Normal stomach. About 60% of breast carcinomas are positive for pS2, especially those that are also positive for estrogen and/or progesterone receptor.
Reactivities Human, Monkey
Host Mouse
Isotype IgG1
Clonality Monoclonal
Immunogen Synthetic peptide of 28 amino acid residues corresponding to amino acids 57-84 from the C-terminus of Human pS2.
Specificity It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of Human pS2 protein.
Cellular Localization: Cytoplasmic.
Formulation 10mM PBS
State: Purified
State: Liquid purified IgG fraction from Bioreactor Concentrate
Stabilizer: 0.05% BSA
Preservative: 0.05% Sodium Azide
Concentration lot specific
Purification Protein A/G Chromatography
Conjugation Unconjugated
Storage Store undiluted at 2-8°C.
Stability Shelf life: one year from despatch.
Predicted Protein Size 6.5 kDa
Gene Name trefoil factor 1
Background Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intrachain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2.
Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy.
Synonyms TFF1, BCEI, Breast cancer estrogen-inducible protein, PNR-2
Reference Data

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.